https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/conference-coverage

The Latest

Lipids Respond Well to Switch From Boosted PI to Rilpivirine/Tenofovir/Emtricitabine (Complera), Study Finds Img

Lipids Respond Well to Switch From Boosted PI to Rilpivirine/Tenofovir/Emtricitabine (Complera), Study Finds

Many people who had high lipid levels while taking common HIV treatment regimens that included a protease inhibitor, such as Prezista or Reyataz, saw remarkable improvements after the switch.

The Latest on HIV and Kidney, Heart and Bone Health (Video) Img

The Latest on HIV and Kidney, Heart and Bone Health (Video)

How much HIV drugs contribute to organ health problems in long-term HIV med users, and ways to prevent these problems, is a hot topic in medical communities.

Vicks Vaporub Works as Treatment for Foot Fungus in HIV-Infected Individuals, Study Finds Img

Vicks Vaporub Works as Treatment for Foot Fungus in HIV-Infected Individuals, Study Finds

Vicks VapoRub may be a cheap, effective and safe topical treatment for foot fungus (also known as onychomycosis) among people living with HIV, according to results from a pilot study presented at ID Week 2012.

Onychomycosis is common in both the gen...

Promo Image

Reyataz and Kidney Stones

Reyataz, one of two preferred HIV protease inhibitor (PI) medications under U.S. treatment guidelines, is associated with the risk of kidney stones and other potential renal abnormalities. According to Japanese researchers, people taking Norvir-boost...

Pilot Program Increases Cervical Cancer Screening by 42% Among Women Living With HIV Img

Pilot Program Increases Cervical Cancer Screening by 42% Among Women Living With HIV

Because women with HIV have higher rates of cervical cancer than HIV-negative women, cervical cancer screening should be performed annually. However, many women never get screened. Here's how a program in St. Louis reversed the trend.

Promo Image

Efavirenz Interaction Studies With TB Compounds Bedaquiline and Delamanid

HIV and TB co-infection is common and treatment is complicated by drug-drug interactions.

Two poster presentations at ICAAC described potential reduced exposure of bedaquiline and a lack of interaction with delamanid when co-administered with efavi...

Ongoing HIV Infection Could Explain Low CD4 Counts Despite Undetectable Viral Loads, Study Suggests Img

Ongoing HIV Infection Could Explain Low CD4 Counts Despite Undetectable Viral Loads, Study Suggests

Even if people start HIV treatment late, they still have a good chance at recovery. However, not everyone benefits equally: For instance, some people seem to have poor CD4 count gains even when HIV meds are working well. New research explores why....

HIV Status Tied to Greater Risk of Death Following Heart Attack, Large Examination of Hospital Records Finds Img

HIV Status Tied to Greater Risk of Death Following Heart Attack, Large Examination of Hospital Records Finds

HIV-positive people who are hospitalized with acute myocardial infarction are more likely to die than their HIV-negative counterparts, U.S. researchers have found. The findings add to the growing body of evidence suggesting that close monitoring of h...

Promo Image

First Report: Atazanavir-Related Gallstones (Cholelithiasis)

A poster presentation included the first report of atazanavir-related gallstones.

Following two cases of gallstones in patients on atazanavir reported to the pharmacovigilence departments of two hospitals in western France, Poinsignon and colleagues...

Promo Image

STIs and HIV: The Tie and Why It Matters

It's no secret that connections exist between HIV and other sexually transmitted infections (STIs), but researchers are pushing for more coordination to reduce the incidence of all such conditions.

Two sessions at AIDS 2012 looked at the correlation...